SOPHSOPHiA Genetics SA
SOPH
SOPHiA Genetics SA255
Mkt Cap
$363.36MVolume
58.0052W High
$5.7052W Low
$2.59PE Ratio
-4.29SOPH Fundamentals
Price
$5.02Prev Close
$5.07Open
$5.1250D MA
$4.85Beta
0.90Avg. Volume
95,955.82EPS (Annual)
-$1.17P/B
7.29Rev/Employee
$186,195.18$308.14
Compact View
Not available
Not available
Poll
Earnings Recap
• Reported GAAP EPS of -$0.27 down -3.85% YoY • Reported revenue of $21.69M up 21.99% YoY • SOPHIA GENETICS reaffirms FY2026 revenue guidance of $92M to $94M, reflecting 20%-22% year-over-year growth, and projects an Adjusted EBITDA loss between $29M and $32M, an improvement from FY2025.
Bullish
SOPHIA GENETICS achieved 22% revenue growth and expanded its customer base, with Net Dollar Retention increasing to 117%. The company also saw strong adoption of new applications like Liquid Biopsy.
Bearish
SOPHIA GENETICS reported increased IFRS net losses and persistent Adjusted EBITDA losses. The company's non-IFRS measures exclude significant recurring expenses and ongoing litigation costs.